1. Home
  2. SYRE vs DAKT Comparison

SYRE vs DAKT Comparison

Compare SYRE & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • DAKT
  • Stock Information
  • Founded
  • SYRE 2013
  • DAKT 1968
  • Country
  • SYRE United States
  • DAKT United States
  • Employees
  • SYRE N/A
  • DAKT N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • DAKT Office Equipment/Supplies/Services
  • Sector
  • SYRE Health Care
  • DAKT Industrials
  • Exchange
  • SYRE Nasdaq
  • DAKT Nasdaq
  • Market Cap
  • SYRE 841.4M
  • DAKT 710.0M
  • IPO Year
  • SYRE 2016
  • DAKT 1994
  • Fundamental
  • Price
  • SYRE $15.72
  • DAKT $16.21
  • Analyst Decision
  • SYRE Buy
  • DAKT Strong Buy
  • Analyst Count
  • SYRE 6
  • DAKT 1
  • Target Price
  • SYRE $55.00
  • DAKT $26.00
  • AVG Volume (30 Days)
  • SYRE 673.0K
  • DAKT 506.5K
  • Earning Date
  • SYRE 08-06-2025
  • DAKT 09-03-2025
  • Dividend Yield
  • SYRE N/A
  • DAKT N/A
  • EPS Growth
  • SYRE N/A
  • DAKT N/A
  • EPS
  • SYRE N/A
  • DAKT N/A
  • Revenue
  • SYRE N/A
  • DAKT $756,477,000.00
  • Revenue This Year
  • SYRE N/A
  • DAKT $9.98
  • Revenue Next Year
  • SYRE N/A
  • DAKT $6.80
  • P/E Ratio
  • SYRE N/A
  • DAKT N/A
  • Revenue Growth
  • SYRE N/A
  • DAKT N/A
  • 52 Week Low
  • SYRE $10.91
  • DAKT $10.24
  • 52 Week High
  • SYRE $40.26
  • DAKT $19.89
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 51.34
  • DAKT 59.38
  • Support Level
  • SYRE $14.97
  • DAKT $15.87
  • Resistance Level
  • SYRE $16.92
  • DAKT $16.78
  • Average True Range (ATR)
  • SYRE 1.12
  • DAKT 0.83
  • MACD
  • SYRE 0.02
  • DAKT 0.11
  • Stochastic Oscillator
  • SYRE 58.05
  • DAKT 78.02

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

Share on Social Networks: